Next Article in Journal
Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium
Next Article in Special Issue
Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens
Previous Article in Journal
A Methodological Framework for Assessing the Benefit of SARS-CoV-2 Vaccination following Previous Infection: Case Study of Five- to Eleven-Year-Olds
Previous Article in Special Issue
IgG1-Dominant Antibody Response Induced by Recombinant Trimeric SARS-CoV-2 Spike Protein with PIKA Adjuvant
 
 
Article

Article Versions Notes

Vaccines 2023, 11(5), 989; https://doi.org/10.3390/vaccines11050989
Action Date Notes Link
article xml file uploaded 16 May 2023 16:29 CEST Original file -
article xml uploaded. 16 May 2023 16:29 CEST Update https://www.mdpi.com/2076-393X/11/5/989/xml
article pdf uploaded. 16 May 2023 16:29 CEST Version of Record https://www.mdpi.com/2076-393X/11/5/989/pdf
article supplementary file uploaded. 16 May 2023 16:29 CEST - https://www.mdpi.com/2076-393X/11/5/989#supplementary
article html file updated 16 May 2023 16:30 CEST Original file https://www.mdpi.com/2076-393X/11/5/989/html
Back to TopTop